Researchers found that pre-existing immunity to Cytomegalovirus (CMV) can limit its transmission during pregnancy and protect against associated birth defects. The study marks an important step toward the development of a vaccine to protect mothers and their babies against the virus, which is a leading cause of miscarriage and birth defects.
Read more https://www.sciencedaily.com/releases/2023/10/231005161757.htm